In the past few years, there's growing attention on the drug sector in this country. While international giants previously held significant influence, a change appears to be happening . Numerous domestic firms have seen considerable progress, challenging the existing structure . Questions are now being asked about whether this represents a genuine

The pharmaceutical landscape in this country is increasingly characterized by a tendency toward market consolidation, with a handful of large companies wielding significant control. These industry giants, often bolstered by long-standing distribution networks and considerable brand recognition, present a complex picture for competition and budget-f

India's pharmaceutical landscape presents a complex picture, largely shaped by the considerable influence of a few dominant players. While the sector is often lauded for its generic drug manufacturing capabilities, a closer examination reveals a degree of market concentration that warrants scrutiny. These traditional companies, including names like